Clinical Trial Update: Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients [Phase 1]

View source ↗

Summary

Phase 1 trial investigating botulinum toxin for seborrheic dermatitis in Parkinsonian patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinsonism
• Seborrheic Dermatitis

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Parkinson Disease, Parkinsonism | Phase 1 | Status: UNKNOWN